Clinicopathologic significance of cyclooxygenase-2 overexpression in colorectal adenocarcinoma

Basic and Applied Pathology

Volumn 3, Issue 1, 2010, Pages 14-20

  Jang, Se Min ^a   Jun, Young Jin ^a   Na, Woong ^a   Jang, Si Hyong ^a   Min, Kyueng Whan ^a   Song, Young Soo ^a   Jang, Ki Seok ^a   Han, Hong Xiu ^b   Lee, Kang Hong ^a   Paik, Seung Sam ^a  

^a Hanyang University   (South Korea)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Adenocarcinoma; Colorectum; COX 2; P53; Prognosis; Survival

Indexed keywords

EID: 77955635829     PISSN: None     EISSN: 17559294     Source Type: Journal    
DOI: 10.1111/j.1755-9294.2009.01064.x     Document Type: Article

References (41)

1. Friedlich MS, Stern HS. Primary prevention: what can you tell your patient?. Surg Oncol Clin N Am 2000, 9:655-60.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33.
3. Walker J, Quirke P. Prognosis and response to therapy in colorectal cancer. Eur J Cancer 2002, 38:880-6.
4. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K. Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004, 10:8465-71.
5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107:1183-8.
6. Sano H, Kawahito Y, Wilder RL. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995, 55:3785-9.
7. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995, 55:2556-9.
8. Chapple KS, Cartwright EJ, Hawcroft G. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000, 156:545-53.
9. Yamauchi T, Watanabe M, Kubota T. Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 2002, 45:98-103.
10. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 2002, 97:1037-41.
11. Fux R, Schwab M, Thon K, Gleiter CH, Fritz P. Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival. Clin Cancer Res 2005, 11:4754-60.
12. Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005, 23:2840-55.
13. Buchanan FG, DuBois RN. Connecting COX-2 and Wnt in cancer. Cancer Cell 2006, 9:6-8.
14. Wu AW, Gu J, Ji JF, Li ZF, Xu GW. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis. World J Gastroenterol 2003, 9:1990-4.
15. Sheehan KM, Sheehan K, O'Donoghue DP. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 1999, 282:1254-7.
16. Fujita T, Matsui M, Takaku K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 1998, 58:4823-6.
17. Liang JT, Huang KC, Jeng YM. Microvessel density, cyclooxygenase-2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br J Surg 2004, 91:355-61.
18. Masunaga R, Kohno H, Dhar DK. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 2000, 6:4064-8.
19. Rao M, Yang W, Seifalian AM, Winslet MC. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer. Int J Colorectal Dis 2004, 19:1-11.
20. Tomaozawa S, Tsuno NH, Sunami E. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 2000, 83:324-8.
21. van de Rijn M, Gilks CB. Applications of microarray to histopathology. Histopathology 2004, 44:97-108.
22. Jourdan F, Sebbagh N, Comperat E. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 2003, 443:115-21.
23. Castells A, Paya A, Alenda C. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency. Clin Cancer Res 2006, 12:1686-92.
24. Ogino S, Kirkner GJ, Nosho K. Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res 2008, 14:8221-7.
25. Tsujii M, Kawano S, Tsuji S. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93:705-16.
26. Cianchi F, Cortesini C, Bechi P. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001, 121:1339-47.
27. Bertagnolli MM, Eagle CJ, Zauber AG. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006, 355:873-84.
28. Arber N, Eagle CJ, Spicak J. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006, 355:885-95.
29. Yamac D, Celenkoglu G, Coskun U. Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathol Res Pract 2005, 201:497-502.
30. Joo YE, Kim HS, Min SW. Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer 2002, 31:147-54.
31. Xiong B, Sun TJ, Hu WD, Cheng FL, Mao M, Zhou YF. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance. World J Gastroenterol 2005, 11:1105-8.
32. Lim SC, Lee TB, Choi CH, Ryu SY, Kim KJ, Min YD. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers. Yonsei Med J 2007, 48:495-501.
33. Lim SC, Lee TB, Choi CH, Ryu SY, Min YD, Kim KJ. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer. J Surg Oncol 2008, 97:51-6.
34. Nakopoulou L, Mylona E, Papadaki I. Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma. Pathobiology 2005, 72:241-9.
35. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Kaiser GM, Schmid KW, Baba1 HA. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis. J Clin Pathol 2009, 62:690-3.
36. Loong SLE, Hwang JSG, Li HH. Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). Radiat Oncol 2009, 4:23.
37. Bargonetti J, Manfredi JJ. Multiple roles of the tumor suppressor p53. Curr Opin Oncol 2002, 14:86-91.
38. Geyer RK, Nagasawa H, Little JB. Role and regulation of p53 during an ultraviolet radiation-induced G1 cell-cycle arrest. Cell Growth Differ 2000, 11:149-56.
39. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999, 274:10911-5.
40. Sakuma K, Fujimori T, Hirabayashi K, Terano A. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. J Gastroenterol 1999, 34:189-94.
41. Cressey R, Pimpa S, Tontrong W, Watananupong O, Leartprasertsuke N. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression. Cancer Lett 2006, 233:232-9.